
Coenzyme Q10
CAS No. 303-98-0
Coenzyme Q10 ( CoQ10 )
产品货号. M13959 CAS No. 303-98-0
从辅酶Q10中提取;适用性:氯仿、苯和四氯化碳。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
200MG | ¥340 | 有现货 |
![]() ![]() |
500MG | ¥737 | 有现货 |
![]() ![]() |
1G | ¥1102 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Coenzyme Q10
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述从辅酶Q10中提取;适用性:氯仿、苯和四氯化碳。
-
产品描述Extracted from Coenzyme Q10;Suitability:Chloroform,benzene and carbon tetrachloride;Store the product in sealed,cool and dry condition.(In Vitro):Coenzyme Q10 is an obligatory member of the respiratory chain in the mitochondria of all cells. Therefore, it is an essential ingredient in the formation of adenosine triphosphate (ATP), the source of energy in most cellular processes. Coenzyme Q10 is located in the mitochondria, lysosomes, and Golgi and plasma membranes, and provides an antioxidant action either by direct reaction with free radicals or by regeneration of tocopherol and ascorbate from their oxidised state. Coenzyme Q10 is a popular dietary supplement because of its recognition by the public as an important nutrient in supporting human health. The rationale for the use of Coenzyme Q10 as a therapeutic agent in several cardiovascular and degenerative neurologic and neuromuscular diseases is based upon its fundamental role in mitochondrial function and cellular bioenergetics. (In Vivo):Because of its hydrophobicity and large molecular weight, absorption of dietary Coenzyme Q10 is slow and limited. In the case of dietary supplements, solubilized Coenzyme Q10 formulations show enhanced bioavailability. The Tmax is around 6 h, with an elimination half-life of about 33 h. The reference intervals for plasma Coenzyme Q10 range from 0.40 to 1.91 mM in healthy subjects. With Coenzyme Q10 supplements there is reasonable correlation between increase in plasma Coenzyme Q10 and ingested dose up to a certain point. Animal data show that Coenzyme Q10 in large doses is taken up by all tissues including heart and brain mitochondria. In 12-month-old rats administration of coenzyme Q10 results in significant increases in cerebral cortex mitochondrial concentrations of coenzyme Q10. Oral administration of coenzyme Q10 markedly attenuates striatal lesions produced by systemic administration of 3-nitropropionic acid and significantly increases life span in a transgenic mouse model of familial amyotrophic lateral sclerosis.
-
体外实验Coenzyme Q10 is an obligatory member of the respiratory chain in the mitochondria of all cells. Therefore, it is an essential ingredient in the formation of adenosine triphosphate (ATP), the source of energy in most cellular processes. Coenzyme Q10 is located in the mitochondria, lysosomes, and Golgi and plasma membranes, and provides an antioxidant action either by direct reaction with free radicals or by regeneration of tocopherol and ascorbate from their oxidised state. Coenzyme Q10 is a popular dietary supplement because of its recognition by the public as an important nutrient in supporting human health. The rationale for the use of Coenzyme Q10 as a therapeutic agent in several cardiovascular and degenerative neurologic and neuromuscular diseases is based upon its fundamental role in mitochondrial function and cellular bioenergetics.
-
体内实验Because of its hydrophobicity and large molecular weight, absorption of dietary Coenzyme Q10 is slow and limited. In the case of dietary supplements, solubilized Coenzyme Q10 formulations show enhanced bioavailability. The Tmax is around 6 h, with an elimination half-life of about 33 h. The reference intervals for plasma Coenzyme Q10 range from 0.40 to 1.91 mM in healthy subjects. With Coenzyme Q10 supplements there is reasonable correlation between increase in plasma Coenzyme Q10 and ingested dose up to a certain point. Animal data show that Coenzyme Q10 in large doses is taken up by all tissues including heart and brain mitochondria. In 12-month-old rats administration of coenzyme Q10 results in significant increases in cerebral cortex mitochondrial concentrations of coenzyme Q10. Oral administration of coenzyme Q10 markedly attenuates striatal lesions produced by systemic administration of 3-nitropropionic acid and significantly increases life span in a transgenic mouse model of familial amyotrophic lateral sclerosis.
-
同义词CoQ10
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Other Indications
-
适应症——
化学信息
-
CAS Number303-98-0
-
分子量863.37
-
分子式C59H90O4
-
纯度>98% (HPLC)
-
溶解度Ethanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)
-
SMILESO=C(C(OC)=C1OC)C(C)=C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)\C)C1=O
-
化学全称2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Crane FL, J Am Coll Nutr, 2001, 20(6), 591-598.
产品手册




关联产品
-
Ganolucidic acid B
Ganolucidic acids B showd induction ability of hPXR-mediated CYP3A4 expression.
-
Stiripentol
Stiripentol (STP) 是一种抗惊厥药,可抑制 CYP3A4(非竞争性)和 CYP2C19(竞争性)介导的 CLB N-去甲基化为 NCLB,Ki 为 1.59/0.516 μM,IC50 为 1.58/3.29 μM。
-
PZ-2891
PZ-2891 是一种口服生物可利用的脑渗透性泛酸激酶 (PANK) 调节剂 (hPANK3,IC50:1.3 nM)。